Subtopic Deep Dive
Canine Mast Cell Tumor Grading
Research Guide
What is Canine Mast Cell Tumor Grading?
Canine Mast Cell Tumor Grading develops histological systems to classify cutaneous mast cell tumors in dogs by morphologic features correlating with prognosis and survival.
Patnaik et al. (1984) established a 3-grade morphologic system for 83 canine cutaneous mast cell tumors, linking grades to survival times over 1500 days (834 citations). Kiupel et al. (2010) proposed a standardized 2-tier histologic grading system to predict biological behavior more accurately across institutions (583 citations). Romansik et al. (2007) demonstrated mitotic index as a survival predictor independent of grade (214 citations).
Why It Matters
Accurate grading using Patnaik's 3-grade (Patnaik et al., 1984) or Kiupel's 2-tier system (Kiupel et al., 2010) determines surgical excision margins, adjuvant therapies like toceranib (London et al., 2009), and masitinib (Hahn et al., 2008), directly impacting survival predictions. Romansik et al. (2007) showed mitotic index refines prognosis for intermediate-grade tumors, guiding clinical decisions. Breed predispositions from Dobson (2013) inform genetic screening in high-risk lines like retrievers.
Key Research Challenges
Grading System Variability
Veterinary pathologists apply different schemes, causing inconsistencies in prognosis; Kiupel et al. (2010) noted institutional modifications to Patnaik's system. Standardization efforts like the 2-tier approach improve inter-observer agreement but require validation. Multi-center data is needed for reproducibility.
Prognostic Marker Integration
KIT and tryptase expression (Kiupel et al., 2004) and mitotic index (Romansik et al., 2007) enhance grading but lack unified incorporation. Combining histologic grade with molecular markers improves metastasis prediction. Clinical trials like toceranib (London et al., 2009) highlight need for grade-stratified outcomes.
Breed-Specific Prognosis
Pedigree breeds show variable cancer risks, including mast cell tumors (Dobson, 2013), complicating universal grading. Genetic factors influence tumor behavior beyond histology (Hayward et al., 2016). Tailored grading models per breed remain undeveloped.
Essential Papers
Canine Cutaneous Mast Cell Tumor: Morphologic Grading and Survival Time in 83 Dogs
A. K. Patnaik, William J. Ehler, E. Gregory MacEwen · 1984 · Veterinary Pathology · 834 citations
Eighty-three cutaneous mast cell tumors in the dog were classified morphologically into three grades. The neoplasms were excised surgically, and the dogs were followed for 1500 days. Comparison of ...
Proposal of a 2-Tier Histologic Grading System for Canine Cutaneous Mast Cell Tumors to More Accurately Predict Biological Behavior
Matti Kiupel, Joshua D. Webster, Keith Bailey et al. · 2010 · Veterinary Pathology · 583 citations
Currently, prognostic and therapeutic determinations for canine cutaneous mast cell tumors (MCTs) are primarily based on histologic grade. However, the use of different grading systems by veterinar...
Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
Cheryl A. London, Phyllis B. Malpas, Stacey L. Wood-Follis et al. · 2009 · Clinical Cancer Research · 415 citations
Abstract Purpose: The purpose of this study was to determine the objective response rate (ORR) following treatment of canine mast cell tumors (MCT) with toceranib phosphate (Palladia, SU11654), a k...
Breed-Predispositions to Cancer in Pedigree Dogs
Jane Dobson · 2013 · ISRN Veterinary Science · 324 citations
Cancer is a common problem in dogs and although all breeds of dog and crossbred dogs may be affected, it is notable that some breeds of pedigree dogs appear to be at increased risk of certain types...
Masitinib is Safe and Effective for the Treatment of Canine Mast Cell Tumors
K. Hahn, G. Oglivie, Todd Rusk et al. · 2008 · Journal of Veterinary Internal Medicine · 279 citations
Background: Activation of the KIT receptor tyrosine kinase is associated with the development of canine mast cell tumors (MCT). Hypothesis/Objective: To evaluate the efficacy of masitinib, a potent...
Complex disease and phenotype mapping in the domestic dog
Jessica J. Hayward, Marta G. Castelhano, Kyle C. Oliveira et al. · 2016 · Nature Communications · 273 citations
The Use of KIT and Tryptase Expression Patterns as Prognostic Tools for Canine Cutaneous Mast Cell Tumors
Matti Kiupel, Joshua D. Webster, John B. Kaneene et al. · 2004 · Veterinary Pathology · 249 citations
Cutaneous mast cell tumors (MCTs) are one of the most common tumors in dogs. Currently, prognostic and therapeutic determinations for MCTs are primarily based on the histologic grade of the tumor, ...
Reading Guide
Foundational Papers
Start with Patnaik et al. (1984) for original 3-grade system and survival data from 83 dogs; follow with Kiupel et al. (2010) for standardized 2-tier addressing inconsistencies; add Romansik et al. (2007) for mitotic index refinement.
Recent Advances
Study London et al. (2009) for toceranib outcomes by grade; Hahn et al. (2008) masitinib efficacy; Dobson (2013) breed risks influencing grading applications.
Core Methods
Morphologic assessment of cytoplasmic granulation, nuclei, mitoses (Patnaik 1984); 2-tier criteria of karyomegaly and count (Kiupel 2010); mitotic index per high-power field (Romansik 2007); KIT immunohistochemistry (Kiupel 2004).
How PapersFlow Helps You Research Canine Mast Cell Tumor Grading
Discover & Search
Research Agent uses searchPapers and citationGraph to map Patnaik et al. (1984) as the foundational 3-grade system with 834 citations, then findSimilarPapers reveals Kiupel et al. (2010) 2-tier proposal resolving inconsistencies. exaSearch uncovers Romansik et al. (2007) on mitotic index for intermediate grades.
Analyze & Verify
Analysis Agent applies readPaperContent to extract survival data from Patnaik et al. (1984), then runPythonAnalysis with pandas computes Kaplan-Meier curves from raw counts; verifyResponse (CoVe) with GRADE grading confirms Kiupel et al. (2010) inter-observer stats, flagging contradictions in older schemes.
Synthesize & Write
Synthesis Agent detects gaps like unintegrated KIT markers from Kiupel et al. (2004), flags contradictions between 3-tier and 2-tier survival predictions; Writing Agent uses latexEditText for grading comparison tables, latexSyncCitations for 10-paper bibliography, latexCompile for prognosis flowchart, and exportMermaid for mitotic index decision trees.
Use Cases
"Run survival analysis on Patnaik 1984 mast cell tumor grades using Python"
Research Agent → searchPapers('Patnaik 1984') → Analysis Agent → readPaperContent → runPythonAnalysis(pandas Kaplan-Meier on 83-dog survival data) → matplotlib survival plot output.
"Compare Kiupel 2-tier vs Patnaik 3-grade systems in LaTeX table"
Research Agent → citationGraph(Kiupel 2010) → Synthesis Agent → gap detection → Writing Agent → latexEditText(table), latexSyncCitations(10 papers), latexCompile → PDF with graded prognosis summary.
"Find code for canine MCT mitotic index calculation"
Research Agent → searchPapers('Romansik 2007 mitotic index') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis on extracted MI script → verified prognostic calculator.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'canine mast cell tumor grading', structures report with Patnaik (1984) to London (2009) timelines, GRADE-scores evidence. DeepScan applies 7-step CoVe to Kiupel et al. (2010) validation data, checkpoint-verifies 2-tier metrics against Romansik (2007). Theorizer generates hypotheses integrating KIT expression (Kiupel 2004) with breed risks (Dobson 2013).
Frequently Asked Questions
What is the definition of canine mast cell tumor grading?
Histological classification of canine cutaneous mast cell tumors into grades based on morphology, correlating with survival; Patnaik et al. (1984) defined 3 grades from 83 dogs.
What are the main grading methods?
Patnaik 3-grade (1984) uses pleomorphism and mitoses; Kiupel 2-tier (2010) standardizes low/high based on 2 criteria for better prognosis; Romansik adds mitotic index (2007).
What are key papers on canine MCT grading?
Patnaik et al. (1984, 834 citations) introduced 3-grade; Kiupel et al. (2010, 583 citations) proposed 2-tier; Romansik et al. (2007, 214 citations) validated mitotic index.
What are open problems in MCT grading?
Integrating molecular markers like KIT (Kiupel 2004) with histology; breed-specific adjustments (Dobson 2013); validating combined scores in multi-center trials.
Research Veterinary Oncology Research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Canine Mast Cell Tumor Grading with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Veterinary Oncology Research Research Guide